Provision of signed and dated written informed consent prior to any study-specific procedures, sampling, and analyses. If a patient declines to participate in any voluntary exploratory research and/or genetic component of the study, there will be no penalty or loss of benefit to the patient and he/she will not be excluded from other aspects of the study.
Patient must consent to the study and provide a signed and dated, written informed consent document prior to any study-specific procedures, sampling, or analyses.
For inclusion in the optional PGx research, patients must provide informed consent for the genetic sampling and analyses.
Provision of signed and dated, written informed consent prior to any study specific procedures, sampling and analyses; including access to all archival tumour tissue (diagnostic and/or most recent samples)
Provide informed consent for genetic sampling and analyses
Provision of signed and dated, written Informed Consent Form (ICF) prior to any trial-specific procedures, sampling, or analyses. If a patient declines to participate in the voluntary pharmacogenetics component of the trial, he/she will not be excluded from other aspects of the trial.
Provision of signed and dated, written informed consent prior to any study-specific procedures, sampling and analyses.
Ability to understand and the willingness to sign a written informed consent document prior to any study specific procedures, sampling, and analyses
Provision of informed consent prior to any study specific procedures, sampling and analyses.
Provision of signed and dated, written informed consent prior to any study specific procedures, sampling and analyses
Ability to understand and the willingness to sign a written informed consent document prior to any study specific procedures, sampling, and analyses
Provision of signed and dated written informed consent prior to any study specific procedures, sampling analysis
